University of Pennsylvania
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Pennsylvania sits in the top decile of US sponsors by registered trial count (#15 of 15,751 sponsors by registered trial count).
University of Pennsylvania: 1,423 sponsored US clinical trials, 199 recruiting.
University of Pennsylvania sponsors 1,423 registered US clinical trials on ClinicalTrials.gov, 199 of them currently recruiting, and 982 completed. 130 of these trials are in Phase 3-4 (later-stage) and 339 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 17 trials.
Top-decile sponsor footprint
University of Pennsylvania ranks in the top decile of sponsors by registered trial count (#15 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
1,423 total, page 17 of 29
The Weigh Forward, Financial Incentives for Maintenance of Weight Loss
NCT02538783
The Healthy Patterns Sleep Study
NCT03682185
Transplanting Hepatitis C Kidneys Into Negative Kidney Recipients
NCT02743897
A Comparison of Web-Prolonged Exposure (Web-PE) and Present-Centered Therapy (PCT) for PTSD Among Active-Duty Military Personnel
NCT02556645
Trial Of NS2359 For The Treatment of Cocaine Dependence
NCT02798627
Neural Mechanisms Associated With Risk of Smoking Relapse
NCT02837510
Targeting Central Pulsatile Hemodynamics in Chronic Kidney Disease
NCT02791906
Neural Mechanisms Underlying the Antidepressant Effects of Sleep Deprivation
NCT03169543
Effects of Metformin During Nicotine Withdrawal
NCT03593538
Ultrasound Assessment of Ventral Hernia Defects
NCT03043079
A Test of Neural Inertia in Humans With Xenon
NCT02768727
Screening Protocol for a Gene Therapy Trial in Subjects With Homozygous Familial Hypercholesterolemia
NCT03018678
Registry of Patients With CardioMEMS
NCT02729922
Mobile Technology Monitoring System to Assess a Web-based Intervention for Teen Risky Driving
NCT02695888
Feasibility of a Behavioral Activation Trial
NCT02992158
Randomized Evaluation of Default Access to Palliative Services
NCT02505035
Default Options to Reduce Unnecessary Daily Imaging During Palliative Radiation
NCT03110692
Regional Versus General Anesthesia for Promoting Independence After Hip Fracture
NCT02507505
Unlock the Cell: Castleman's Disease Flow Cytometry Study
NCT02853968
Pilot Trial Of Autologous T Cells Engineered To Express Anti-CD19 Chimeric Antigen Receptor (CART19)In Combination With Ibrutinib In Patients With Relapsed Or Refractory CD19+ Chronic Lymphocytic Leukemia (CLL)Or Small Lymphocytic Lymphoma (SLL)
NCT02640209
Vascepa to Accelerate Lipoprotein Uptake and Elimination
NCT03885661
Outcomes of Opioid Addicted Prisoners With Extended-Release Injectable Naltrexone
NCT02617628
The Effect of Repeated Prefrontal Cortex Stimulation on Antisocial and Aggressive Behavior
NCT02674516
Behavioral Economic Incentives to Improve Glycemic Control Among Adolescents and Young Adults
NCT02568501
IMPACT STUDY: Investigating Microbial Pathogen Activity of Copper Textiles
NCT02627092
CPR Education Via a Mobile Application Compared to VSI Kit
NCT02548793
VectorFlow Tunneled Dialysis Catheter (TDC) Versus Palindrome TDC
NCT02685995
Detection of Cerebral Ischemia With a Noninvasive Neurometabolic Optical Monitor
NCT02983786
Acetaminophen/Codeine vs Acetaminophen/Ibuprofen for Pain Control and Patient Satisfaction After Hand Surgery
NCT02647788
CD123 Redirected Autologous T Cells for AML
NCT02623582
Single Shot vs 24hr vs 48hr Continuous Adductor Canal Block After TKA
NCT02730728
Lumbar Plexus Block vs Fascia Iliaca Block After Hip Arthroscopy
NCT02882633
Connected Health Blood Pressure Monitoring In Stroke and TIA Patients
NCT02450760
Design of an Affordable Gym for Post Stroke Rehabilitation
NCT02820480
Measurement of Individual Level of Abortion Stigma Study
NCT02672605
tDCS Effects on Resisting Smoking: Dose Ranging Study
NCT02624284
Alpha Lipoic Acid in Geographic Atrophy
NCT02613572
Pilot Study of Non-Viral, RNA-Redirected Autologous T Cells in Patients With Refractory or Relapsed Hodgkin Lymphoma
NCT02624258
Variability in Response to Non-steroidal Anti-inflammatory Drugs
NCT02502006
[18F]FES PET/CT in Endocrine Refractory Breast Cancer
NCT02409316
Gut Microbiome and p-Inulin in Hemodialysis
NCT02572882
Improving Coordination and Transitions of Care in Stroke Patients
NCT02642744
Pilot Study of Autologous Anti-CD22 Chimeric Antigen Receptor Redirected T Cells In Patients With Chemotherapy Resistant Or Refractory Acute Lymphoblastic Leukemia
NCT02588456
Intraoperative Imaging of Pituitary Adenomas by OTL
NCT02629549
Topical Irrigation Therapy for CRS
NCT02630472
CART-BCMA Cells for Multiple Myeloma
NCT02546167
Corneal Nerve Structure in Sjogren's
NCT03203382
Effect of Ramelteon on Smoking Abstinence
NCT02560324
Study Evaluating the Use of MRI on CMS Patients
NCT02513056
Trans-MAPP Symptom Patterns Study (SPS)
NCT02514265
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 182 |
| Phase 2 | 157 |
| Phase 3 | 43 |
| Phase 4 | 87 |
Therapeutic Areas
What is open in the University of Pennsylvania pipeline
199 recruiting of 1,423 indexed (14% open); 982 completed (69%).
Phase mix: 130 late (III/IV) vs 339 early (I/II) (early-phase heavy).
Top condition: Obesity (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.